Within the field of drug discovery, there is a highly unusual statistic that defies standard expectations. Going all the way back to the 1950s, the financial investment required to launch a new drug, when adjusted for inflation, has multiplied by two approximately every nine years. Industry experts have dubbed this phenomenon Eroom's Law because it essentially acts as Moore's Law operating backwards. At this point, no one doubts the actual existence of this trend, leaving the true mystery as to what exactly is driving it.